Print Page | Contact Us | Sign In | Join FSN
IgA Nephropathy Clinical Trials
 IgA Nephropathy 

Name or Title of Research Study
Randomized, Double-Blind, Placebo Controlled Study To Evaluate Efficacy And Safety of Nefecon in Patients With Primary Iga Nephropathy (NefIgArd)

Enrollment Criteria
Treatment of primary immunoglobulin A nephropathy (IgAN). Male or female who is 18+ years of age, diagnosed with IgAN with biopsy verification within the 10 years, on a stable dose of RAS inhibitor therapy and has an eGFR between 35 mL/min per 1.73 m2 and 90 mL/min per 1.73 m2

Treatment:  Nefecon v. Placebo

Institution: UF Nephrology

Contact for Enrollment
Sherry Brown, BSN, RN, Clinical Trials Manager
sherry.brown@medicine.ufl.edu |  352-273-5661


IgA Nephropathy 

Title of Research Study
PROTECT: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE-CONTROL STUDY OF THE EFFICACY AND SAFETY OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY

PI: Dr. Contreras, Dr. Drexler, Dr. Fornoni
Sponsor: Retrophin Inc.
Drug:  Sparsentan

Institution: UM Nephrology
Contact for Enrollment:
Jacqueline Vassallo, CCRP.
jvassall@med.miami.edu
Tel: 305-243-4691 


IgA Nephropathy 

Title of Research Study
OMEROS OMS721-IGA-001: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF THE SAFETY AND EFFICACY OF OMS721 IN PATIENTS WITH IMMUNOGLOBULIN A (IGA) NEPHROPATHY (ARTEMIS - IGAN)

PI: Dr. Contreras, Dr. Sosa
Sponsor: Omeros Corporation
Drug:  OMS721

Institution: UM Nephrology
Contact for Enrollment:
Jacqueline Vassallo, CCRP.
jvassall@med.miami.edu
Tel: 305-243-4691 


IgA, FSGS, MN, MCD

Title of Research Study: NEPTUNE: The Nephrotic Syndrome Study Network

PI: Dr. Fornoni, Dr.Contreras, Dr. Lenz
Sponsor: NIH-Office of Rare Kidney Disease-NIDDK, DHHS-NephCure Kidney International, The University of Michigan
Active/Enrolled/InScreening:  4/51/1 

Institution: UM Nephrology
Contact for Enrollment:
Jacqueline Vassallo, CCRP.
jvassall@med.miami.edu
Tel: 305-243-4691 


IgA, FSGS, MN, MCD

Title of Research Study:  CureGN: Cure Glomerulonephropathy Network

PI:  Dr. Fornoni, Dr.Contreras, Dr. Lenz
Sponsor:  NIH-NIDDK-NephCure Kidney International
Active/Enrolled/InScreening:   7/10/0

Institution: UM Nephrology
Contact for Enrollment:
Jacqueline Vassallo, CCRP.
jvassall@med.miami.edu
Tel: 305-243-4691 


FLORIDA SOCIETY OF NEPHROLOGY
1215 E. Robinson Street, Orlando, FL 32801
Phone: 813-909-0450  |  Fax: 813-949-8994